There are 2949 resources available
1018TiP - ALTER-H-004: A phase II study of anlotinib combined with TACE as adjuvant therapy in hepatocellular carcinoma patients at high risk of post-surgery recurrence
Presenter: Zheng Wu
Session: E-Poster Display
Resources:
Abstract
1028P - Clinical results of a pilot trial of GEN-009, a neoantigen vaccine containing immunogenic tumour specific neoantigens, in combination with PD-1 inhibitors in advanced cancers
Presenter: Maura Gillison
Session: E-Poster Display
Resources:
Abstract
1029P - Addition of dendritic cell vaccines to neoadjuvant chemotherapy in HER2 negative breast cancer patients
Presenter: Amaia Urrizola
Session: E-Poster Display
Resources:
Abstract
1030P - First-in-human study of camidanlumab tesirine (ADCT-301, Cami), an anti-CD25 targeted therapy in patients (pts) with advanced solid tumours: Pharmacokinetics (PK) and biomarker evaluation
Presenter: Igor Puzanov
Session: E-Poster Display
Resources:
Abstract
1031P - Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
Presenter: Hani Babiker
Session: E-Poster Display
Resources:
Abstract
1032P - Safety data from stratum D of the phase I INSIGHT platform trial evaluating feasibility of IMP321 (LAG-3Ig protein, eftilagimod alpha) combined with avelumab in advanced stage solid tumour entities
Presenter: Thorsten Goetze
Session: E-Poster Display
Resources:
Abstract
1033P - The phase I INSIGHT platform trial: Strata A and B evaluating feasibility of intratumoral and intraperitoneal IMP321 (soluble LAG-3 protein, eftilagimod alpha) in advanced solid tumours
Presenter: Salah-Eddin Al-Batran
Session: E-Poster Display
Resources:
Abstract
1034P - Camrelizumab in the treatment of patients with local advanced/metastatic esophageal squamous cell carcinoma (ESCC): A multi-center, prospective, cohort study
Presenter: Qun Zhu
Session: E-Poster Display
Resources:
Abstract
1035P - Effect of gut microbiota on immunotherapy of advanced NSCLC
Presenter: Feiyu Zhang
Session: E-Poster Display
Resources:
Abstract
1036P - Patients’ sex and PD-L1 expression jointly associated with overall survival benefits of immune checkpoint inhibitors in cancer
Presenter: Yunfang Yu
Session: E-Poster Display
Resources:
Abstract